Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism

• Main Authors: Xiaoying Zhang (Author), Zhiying Zhang (Author), Pengxiang Wang (Author), Yiwei Han (Author), Lijun Liu (Author), Jie Li (Author), Yichun Chen (Author), Duxia Liu (Author), Jinying Wang (Author), Xiaoying Tian (Author), Qin Zhao (Author), Fengxia Yan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bawei Chenxiang Wan (BCW), a well-known traditional Chinese Tibetan medicine formula, is effective for the treatment of acute and chronic cardiovascular diseases. In the present study, we investigated the effect of BCW in cardiac hypertrophy and underlying mechanisms. The dose of 0.2, 0.4, and 0.8 g...